By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Innovus Pharma 

4275 Executive Square
Suite 200
La Jolla  California  92037  U.S.A.
Phone: 858-964-5123 Fax: 858-964-2301



Company News
Innovus Pharma Announces Successful Top Line Clinical Results From Sensum+(R) in Diabetic And Non-Diabetic Circumcised Men With Low Penile Sensitivity 11/20/2015 12:42:14 PM
Innovus Pharma Announces Formal Of A Clinical Advisory Board To Support The Launch Of Its Androferti Product In The United States 11/13/2015 12:47:06 PM
Innovus Pharma Announces Publication Of Fifth Successful Clinical Trial Involving Androferti 11/5/2015 10:30:33 AM
Hans Christinger Joins Innovus Pharma's Advisory Board 11/3/2015 12:37:23 PM
Innovus Pharma Added To The OTCQB Venture Index 10/30/2015 12:37:39 PM
Innovus Pharma Expands Its Men's And Women's Health Franchise With The Addition Of Exclusive Rights To Androvit To Support Overall Male Prostate And Sexual Health And Urocis XR For Urinary Tract Infection (UTI) For Women From Q Pharma Spain 10/27/2015 9:53:26 AM
Innovus Pharma Announces Sensum+ To Directly Increase Sensitivity In Pre-Clinical Studies Supporting Its Mechanism Of Action And The Human Use Experience 10/21/2015 10:52:36 AM
Innovus Pharma Announces Podium Presentation At The World Meeting Of Sexual Medicine, Discussing The Clinical Efficacy Of Zestra® In Cancer Patients 10/2/2014 7:59:57 AM
Innovus Pharma Strikes $171.25 Million Zestra Deal With Sothema Laboratories 9/24/2014 6:07:00 AM
Innovus Pharma, Orimed Pharma Ink $94.5 Million+ Zestra® Pact 9/22/2014 7:35:35 AM